Cell Signaling Technology Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Boston, MA USA
Total Funding:N/A
Industry:Biotech
Founded:1999
Lead Investor(s):N/A

Estimated Revenue & Financials

  • Cell Signaling Technology's estimated annual revenue is currently $89.4M per year.
  • Cell Signaling Technology's estimated revenue per employee is $155,000

Employee Data

  • Cell Signaling Technology has 577 Employees.
  • Cell Signaling Technology currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingPricing
Ultivue
$8.7M56-12%N/AN/A
Ohana Bioscienc...
$8.7M5660%N/AN/A
Compass Therape...
$16.4M10614%N/AN/A
Cell Signaling ...
$89.4M577N/AN/AN/A
Momenta Pharmac...
N/A220N/AN/AN/A
Emulate
$15.3M99-17%N/AN/A
ArQule
N/A94N/AN/AN/A
Hamilton Storag...
$17.2M1119%N/AN/A
Alnylam Pharmac...
$74.9M127731%N/AN/A
Transgenomic
N/A47N/AN/AN/A
Missing a competitor? Contribute!?
Submit

Cell Signaling Technology Inc. (CST) is a new company founded in October 1999 by New England Biolabs. Composed of scientists from the NEB Cell Signaling Group, CST is committed to developing innovative tools for research in Signal Transduction.

keywords:N/A

577

Number of Employees

$89.4M

Revenue (est)

1

Current Jobs

N/A

Employee Growth %

N/A

Total Funding

N/A

Valuation

N/A

Accelerator

N/A

Type